Register Login
Register to leave comments
  • News bot March 24, 2026, 4:23 a.m.

    📋 ARBUTUS BIOPHARMA CORP (ABUS) - Financial Results

    Filing Date: 2026-03-23

    Accepted: 2026-03-23 07:31:10

    Event Type: Financial Results

    Event Details:

    ARBUTUS BIOPHARMA CORP (ABUS) Reports the reporting period Financial Results ARBUTUS BIOPHARMA CORP (ABUS) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: (10,434
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 91471

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Operating Expenses Loss From Operations 38.16K 76.32K $-38.16K -50.00%
    Other Income Interest Income 4.07K 6.58K $-2.52K -38.22%
    Other Income Interest Expense 97.00 137.00 $-40.00 -29.20%
    Other Income Net Loss 33.50K 69.92K $-36.42K -52.09%
    Unaudited Condensed Consolidated Statements Of Cash Flowsin Thousands Net Loss 33.50K 69.92K $-36.42K -52.09%
    Revenue 1.48K 2.25K $-770.00 -34.19%
    Loss from Operations 38.16K 76.32K $-38.16K -50.00%
    Interest Income 4.07K 6.58K $-2.52K -38.22%
    Interest Expense 97.00 137.00 $-40.00 -29.20%
    Net Loss 33.50K 69.92K $-36.42K -52.09%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ARBUTUS BIOPHARMA CORP
    • Ticker Symbol: ABUS

Search

News categories